New catheter aims to dissolve dangerous lung clots more precisely
NCT ID NCT07681154
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This pilot study tests a new catheter device designed to deliver clot-dissolving medication directly to blood clots in the lungs of adults with intermediate-risk pulmonary embolism. The goal is to see if the device can be used safely and as intended. All 20 participants will receive treatment with the study device, and researchers will monitor for serious side effects and successful drug delivery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Flow Medical Catheter (catheter-directed thrombolysis device)
What this could lead to
If successful, this device could offer a safer, more targeted way to dissolve dangerous blood clots in the lungs, potentially reducing complications from standard treatment.
What could go wrong
This is a very small pilot study with only 20 participants and no comparison group, so results may not apply broadly. The procedure carries risks such as bleeding or device-related complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM (PE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- LAA Clot Detection via CT in AF Patients - NCT07647939
- Pulmonary Embolism & Right-to-Left Shunts Study NCT07519876
- RE-TyPE Study: Understanding Pulmonary Embolism NCT07491094
- Cost-Effectiveness of VTE Prevention in Gynecolo NCT07455253
- Ultrasound Thrombolysis for Pulmonary Embolism (NCT07452991)
- Optimizing CTPA Scan with New ROI Technique NCT07342374
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••